Asset Management and Disposition
cGMP Biotech Manufacturing Plant

PharmaBioSource partners with Transfer Pricing Associates
TPA Logo

High Potency API Manufacturing Plant

  • Available world-class Bulk Biologics / Vaccine Manufacturing site. For a confidential discussion, contact Bill Wiederseim at 610-888-9806.
  • Available Operating Cell Culture Manufacturing Operation with Contract. For a confidential discussion, contact Bill Wiederseim at 610-888-9806.
  • Please direct questions regarding Pfizer-Wyeth sites to Charlie Shafran at 917-821-7693.

Visit us at BIO 2012 in Boston, MA, June 18-21, Booth # 2709

Welcome to PharmaBioSource.

We are uniquely qualified Life Sciences Consulting and Transaction experts with a focus on Facilities and Products, worldwide. Our mission is to be the most respected consultant and broker of high value pharmaceutical and biological products and facilities in the world.

PharmaBioSource is a Pharmaceutical and Biotechnology capacity, transaction and consulting service company. PharmaBioSource Realty LLC (a division of PharmaBioSource, Inc.), is a facilities transaction company serving the Life Sciences Industry. We assist Pharmaceutical and Biotech companies in managing their capacity needs by creating a market for facilities, products and assets. Our services include:

  • Facility / Product Acquisition and Disposition
  • Asset Management and Disposition
  • Benchmarking
  • Technology Transfer
  • Business Case Development
  • Capacity Assessment
  • Acquisition Due Diligence
  • Manufacturing / Supply Chain Consulting
We maintain a database of available Life Sciences manufacturing facilities worldwide, in API, Sterile, Parenteral, Biotech, Solid Dosage and R&D facilities. For a sampling of available Biologics, Pharmaceutical and Life Sciences facilities we either represent or have knowledge of, click here.

Underlining PharmaBioSource and PharmaBioSource Realty services of facility transaction and disposition, asset management, equipment acquisition and disposition, and product exchange are the following core strengths:

  • Ethics
  • Speed, agility and relationships
  • Knowledge of market activity, transactions and benchmarks
  • Comprehension of Pharmaceutical Industry issues such as:
    • Regulatory, tax strategies, employees, manufacturing, etc.
  • Access within the Life Sciences Industry at the highest levels
  • Industry-specific databases
  • Experience with Pharmaceutical consolidation
  • Technical knowledge of the Life Sciences Industry
  • Inclusion of valuable third-party service providers
    • Pharmaceutical equipment, technology transfer, real estate, employee services

For more information, please contact us.

Copyright ©2011 PharmaBioSource, Inc. All rights reserved. Asset management and disposition. Sitemap